Systemic Lupus Erythematosus: Recent Concepts in Genomics, Pathogenetic Mechanisms, and Therapies

Table 4

Summary of newer therapies for SLE.

Biological agents	Rituximab
	Ocrelizumab
	Belimumab
	Epratuzumab
	Atacicept
	Tocilizumab
	Infliximab
	Abatacept
Anticytokine therapies	Anti-TNFα
	Anti-IFNy
	Anti-interleukin 10
	Anti-interleukin 6 receptor
	Anti-interleukin 1 receptor
	Anti- IFNα
Other techniques	Immunoadsorption
	Anti-C5a
	Peptide therapies
	T cell vaccination
	Costimulation inhibition with anti-CD154
	B cell anergy with abetimus